ClinicalTrials.Veeva

Menu

The Effect of Probiotic Lozenges on White Spot Lesion Development in Orthodontic Patients

J

Jordan University of Science and Technology

Status

Active, not recruiting

Conditions

White Spot Lesion

Treatments

Dietary Supplement: Biogaia L. reuteri Prodentis® lozenges
Dietary Supplement: Hersheyland Ice Breakers Mints sugar free lozenges

Study type

Interventional

Funder types

Other

Identifiers

NCT05738369
JUST20220097

Details and patient eligibility

About

The goal of this randomized clinical trial was to investigate the effect of probiotic lozenges on the development of white spot lesions (WSLs) compared to a positive control, and no treatment.

Full description

Background: Recently, the use of probiotics has emerged as a treatment for prevention of oral cavity diseases including periodontal problems, and initial caries. The objectives of this prospective randomized clinical trial was to investigate the effect of probiotic lozenges on the development of white spot lesions (WSLs) compared to a positive control, and no treatment. Methods: Quantitative light induced fluorescence (QLF) images were taken for three randomly allocated groups (intervention group, n=23; positive control, n=23; negative control, n=24) of patients undergoing orthodontic treatment in three separate occasions (T0: before the start of study; T1: at 6 weeks later; T2: at 3 months after the commencement of the study). Subjects in the intervention group were instructed to take one probiotic lozenge containing two strains of Lactobacillus reuteri twice daily. Sugar-free lozenges were used in the positive control group and no lozenges for the negative control group. The QLF images were analyzed using a dedicated software in order to quantitatively analyze each tooth. The primary outcomes measured were the number of newly developed lesions in each group, lesion area and amount of mineral loss (ΔF). Means and standard deviations were calculated using the Statistical Package for the Social Science (SPSS version 28, Chicago, IL, USA). Split plot ANOVA (SPANOVA) test for repeated measures was used to check differences within and between the three groups regarding lesion area and ΔF. To check which group is different from the others, Tukey's test was used.

Enrollment

75 patients

Sex

All

Ages

17 to 33 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy patients from both sexes
  • Having full fixed orthodontic appliances with expected remaining treatment duration of at least 6 months
  • Optimum oral hygiene
  • Maximum of 3 restored teeth
  • Absence of defective enamel formation in the form of hypocalcification or hypoplasia

Exclusion criteria

  • Patients with poor oral hygiene
  • Defective enamel
  • Extensive restorations
  • Gingival hyperplasia
  • Salivary glands diseases
  • Smoking, alcohol consumption, mouth wash use, antibiotic or probiotic intake in the last 3 months.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

75 participants in 3 patient groups, including a placebo group

Probiotic
Experimental group
Description:
Participants received treatment with Biogaia L. reuteri Prodentis® lozenges
Treatment:
Dietary Supplement: Biogaia L. reuteri Prodentis® lozenges
Sugar free lozenges
Placebo Comparator group
Description:
Participants received Hersheyland Ice Breakers Mints sugar free lozenges
Treatment:
Dietary Supplement: Hersheyland Ice Breakers Mints sugar free lozenges
Negative control
No Intervention group
Description:
Participants received no lozenges or supplements

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems